Close

Rating History for Horizon Therapeutics (HZNP) by Leerink Partners

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/13/2022 Joseph P. Schwartz Downgrade Market Perform
(Outperform)
N/A
(N/A)
112.36
(116.30)
3.51% Details